Natalia Zisman

691 total citations
9 papers, 547 citations indexed

About

Natalia Zisman is a scholar working on Molecular Biology, Epidemiology and Biomaterials. According to data from OpenAlex, Natalia Zisman has authored 9 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Biomaterials. Recurrent topics in Natalia Zisman's work include Nanoparticle-Based Drug Delivery (3 papers), Advanced Breast Cancer Therapies (2 papers) and RNA Interference and Gene Delivery (2 papers). Natalia Zisman is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Advanced Breast Cancer Therapies (2 papers) and RNA Interference and Gene Delivery (2 papers). Natalia Zisman collaborates with scholars based in Canada, United States and New Zealand. Natalia Zisman's co-authors include Lawrence D. Mayer, David Bermudes, Sharon A. Johnstone, Paul Tardi, Troy O. Harasym, Pierrot Harvie, Sherwin Xie, Natashia Harasym, Nancy Dos Santos and Norbert Maurer and has published in prestigious journals such as Blood, Cancer Research and Molecular Cancer Therapeutics.

In The Last Decade

Natalia Zisman

7 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalia Zisman Canada	5	313	234	137	113	108	9	547
Euan C. Ramsay Canada	8	350 1.1×	211 0.9×	142 1.0×	117 1.0×	68 0.6×	9	552
Caifeng Deng China	12	342 1.1×	201 0.9×	268 2.0×	84 0.7×	72 0.7×	16	808
Nancy Wong United States	9	174 0.6×	91 0.4×	55 0.4×	180 1.6×	83 0.8×	18	559
Luisa Vicari Italy	15	285 0.9×	83 0.4×	48 0.4×	141 1.2×	23 0.2×	22	557
Jiuxia Pang United States	17	714 2.3×	92 0.4×	99 0.7×	160 1.4×	184 1.7×	20	970
Francisco J. Cimas Spain	13	330 1.1×	94 0.4×	72 0.5×	199 1.8×	24 0.2×	29	596
Ying Shen China	6	197 0.6×	71 0.3×	57 0.4×	58 0.5×	51 0.5×	10	398
Sankar Jagadeeshan India	14	267 0.9×	119 0.5×	84 0.6×	204 1.8×	20 0.2×	32	585
Xinchun Xu China	11	419 1.3×	203 0.9×	131 1.0×	56 0.5×	25 0.2×	18	663

Countries citing papers authored by Natalia Zisman

Since Specialization

Citations

This map shows the geographic impact of Natalia Zisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalia Zisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalia Zisman more than expected).

Fields of papers citing papers by Natalia Zisman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalia Zisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalia Zisman. The network helps show where Natalia Zisman may publish in the future.

Co-authorship network of co-authors of Natalia Zisman

This figure shows the co-authorship network connecting the top 25 collaborators of Natalia Zisman. A scholar is included among the top collaborators of Natalia Zisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalia Zisman. Natalia Zisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Chen, Grace, et al.. (2024). Abstract LB265: IpY.20: Innovative strategies for post-CDK estrogen receptor (ER)+ metastatic breast cancer (mBC). Cancer Research. 84(7_Supplement). LB265–LB265.

Chen, Grace, Natalia Zisman, Krishna P. Allamneni, & Stacy W. Blain. (2024). Abstract B018: Triple CDK2/4/6 inhibition via p27 modulation: A novel approach to targeting cell cycle dysregulation. Cancer Research. 84(3_Supplement_1). B018–B018.

Arns, Steve, et al.. (2015). Assessing the oral bioavailability of difluorosialic acid prodrugs, potent viral neuraminidase inhibitors, using a snapshot PK screening assay. Bioorganic & Medicinal Chemistry Letters. 25(12). 2505–2509. 3 indexed citations

Donohue, Elizabeth, Anitha Thomas, Norbert Maurer, et al.. (2013). The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model. Journal of Cancer. 4(7). 585–596. 88 indexed citations

Pambid, Mary Rose, Hans Adomat, Kaiji Hu, et al.. (2013). Overcoming resistance to sonic hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma. Pediatric Blood & Cancer. 61(1). 107–115. 40 indexed citations

Zisman, Natalia, Nancy Dos Santos, Sharon A. Johnstone, et al.. (2011). Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations. PubMed. 2011. 1–7. 27 indexed citations

Tardi, Paul, Nancy Dos Santos, Troy O. Harasym, et al.. (2009). Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo. Molecular Cancer Therapeutics. 8(8). 2266–2275. 98 indexed citations

Kim, Peter, Troy O. Harasym, Wah-Seng Lim, et al.. (2009). Improved Selectivity against Acute Myeloid Leukemia (AML) Blasts Over Normal Hematopoietic Progenitors for Cytarabine: Daunorubicin Delivered as CPX-351 Liposome Injection.. Blood. 114(22). 2071–2071. 3 indexed citations

Tardi, Paul, Sharon A. Johnstone, Natashia Harasym, et al.. (2008). In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy. Leukemia Research. 33(1). 129–139. 288 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact